Foreign reference pricing
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed leadership will meet with Japanese officials directly before and after a U.S. Trade Representative meeting in Tokyo the week of Jan. 21. AdvaMed President Pamela Bailey will visit Japan the week of Jan. 14 to discuss trade barriers for medical technologies; Executive VP-Global Strategy & Analysis Edward Rozynski will follow the USTR-Japan meeting with a visit the week of Jan. 28. The trade group backed a letter from Sens. Max Baucus (D-Mont.) and Charles Grassley (R-Iowa) to Prime Minister Junichiro Koizumi, expressing "serious concern" over a Dec. 12, 2001 policy change by the Ministry of Health, Labor and Welfare regarding the adoption of foreign reference pricing rules (1"The Gray Sheet" Dec. 24, 2001, p. 30). Co-signed by Senate leaders Tom Daschle (D-S.D.) and Trent Lott (R-Miss.), the Dec. 20 letter claims the MHLW decision "does not reflect a method that is open, transparent or in accord with free trade principles"...
You may also be interested in...
AdvaMed May Pursue WTO Input If Japanese Trade Issues Go Unresolved
AdvaMed concerns over Japanese foreign reference pricing rules and other matters could be brought before the World Trade Organization if not resolved through ongoing bilateral discussions
Regulatory News In Brief
HHS secretary panel on regulatory reform: Inaugural meeting Jan. 7 at Providence Hospital in Washington, D.C. will precede a series of regional public hearings to solicit comments on proposed regulatory changes concerning medical product development and other issues. A list of committee members, including over 20 health industry officials, will be made available the week of Dec. 24...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.